Sski Solution
NDC Package 71740-112-08
Package Information
Sski (potassium iodide) solution is sSKI® (potassium iodide oral solution, USP) is for use as an expectorant in the symptomatic treatment of chronic pulmonary diseases where tenacious mucus complicates the problem, including bronchial asthma, bronchitis and pulmonary emphysema. This formulation utilizes a solution delivery system. Marketed by Avondale Pharmaceuticals, Llc, this product is identified by NDC 71740-112.
Identification & Billing
- RxCUI: 312541 - potassium iodide 1 GM in 1 mL Oral Solution
- RxCUI: 312541 - potassium iodide 1000 MG/ML Oral Solution
- RxCUI: 312541 - K+ Iodide 1000 MG/ML Oral Solution
- RxCUI: 312541 - Pot Iodide 1000 MG/ML Oral Solution
- RxCUI: 312541 - potassium iodide 1 GM per 1 ML Oral Solution
Clinical Specifications
Regulatory & Marketing
Hierarchy Structure
- 71740 - Avondale Pharmaceuticals, Llc
- 71740-112 - Sski
- 71740-112-08 - 1 BOTTLE in 1 CARTON / 237 mL in 1 BOTTLE
- 71740-112 - Sski
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Other Available Packages
The following commercial packages are registered under the same Product NDC (71740-112). Click a package code to view its specific billing and regulatory data.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 71740-112-08 identifies a specific commercial package of 1 bottle in 1 carton / 237 ml in 1 bottle of Sski, a human prescription drug labeled by Avondale Pharmaceuticals, Llc. This product is billed per "ML" milliliter and contains an estimated amount of 237 billable units per package. This solution is formulated for oral use and contains potassium iodide as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Avondale Pharmaceuticals, Llc on November 13, 2017. The current certification is valid through December 31, 2026.
How is this Avondale Pharmaceuticals, Llc product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 71740011208. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 237 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Product segment to maintain the 5-4-2 structure.